A method of identifying a patient likely to benefit from omega-3 fatty acid therapy for dementia, vascular dementia, Parkinson's dementia, Alzheimer's disease, and/or mild cognitive impairment includes identifying a patient-having abnormal brain activity by conducting one or more baseline scans of the patients brain, administering a first dosage regimen of omega-3 fatty acids to the patient and, thereafter conducting one or more assessment scans of the patient's brain, comparing the one or more assessment scans with the one or more baseline scans to determine any improvement in the patient's brain activity, and selecting any patient having an improvement in brain activity to receive omega-3 fatty acid therapy for the treatment or prevention of dementia, vascular dementia, Parkinson's dementia, Alzheimer's disease, and/or mild cognitive impairment.
METHODS OF IDENTIFYING AND TREATING PATIENTS LIKELY TO BENEFIT FROM OMEGA-3 FATTY ACID THERAPY FOR DEMENTIA, VASCULAR DEMENTIA, PARKINSON'S DEMENTIA, ALZHEIMER'S DISEASE, AND/OR MILD COGNITIVE IMPAIRMENT